Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

NCT04601038 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04601038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04601038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
June 28, 2021
Completion date
January 1, 2028
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, memory impairment, mild cognitive impairment